Indeterminate (B3) breast lesions: experience with vacuum-assisted biopsy under ultrasound guidance-Reference-Cited by-同舟云学术

Indeterminate (B3) breast lesions: experience with vacuum-assisted biopsy under ultrasound guidance

Published:2022-10-19 Issue:3 Volume:13 Page:43-50
ISSN:2079-5343
Container-title:Diagnostic radiology and radiotherapy
language:
Short-container-title:Lučevaâ diagn. ter.

Author:

Busko E. A.¹^ORCID,Mortada V. V.²^ORCID,Krivorotko P. V.²^ORCID,Semiglazov V. F.²^ORCID,Pesotsky R. S.²^ORCID,Emelyanov А. S.²^ORCID,Amirov N. S.²^ORCID,Channov V. S.²^ORCID,Tabagua T. T.²^ORCID,Gigolaeva L. P.²^ORCID,Yerechshenko S. S.²^ORCID,Komyakhov A. V.²^ORCID,Nikolaev K. S.²^ORCID,Zernov K. Y.²^ORCID,Zhiltsova E. K.²^ORCID,Bondarchuk Ya. I.²^ORCID,Enaldieva D. A..²^ORCID,Novikov S. N.²^ORCID,Apollonova V. S.²^ORCID,Tseluiko A. I.²^ORCID,Kasparov B. S.²^ORCID

Affiliation:

1. NMRC of Oncology named after N. N. Petrov of MoH of Russia; St. Petersburg State University

2. NMRC of Oncology named after N. N. Petrov of MoH of Russia

Abstract

INTRODUCTION: Introduction of breast cancer screening programs has led to an increase in detection of non-palpable masses requiring core needle biopsy. Masses that fall into B3 category based on the histological results of core biopsy specimens, are of interest precisely because of their uncertain malignant potential and the lack of a final consensus on their management.OBJECTIVE: To analyze the 3-year experience of ultrasound guided vacuum-assisted biopsy (VAB) in patients with B3 breast lesions based on the results of histological examination of core biopsy specimens.MATERIALS AND METHODS: Between June 2019 and June 2022, 163 VABs were performed. The study group included patients with category 2–4 breast lesions according to the BI-RADS scoring system. The decision to perform VAB was made by the oncologist in each specific case on the basis of anamnesis, clinical data and the results of core biopsy histological examination: in cases of B3 or B2 lesions with a discordant radiologic pattern.RESULTS: In 155 (95.0%) cases, the removed lesions were benign, invasive cancer was detected in 2 (1.2%) cases, ductal cancer in situ in 6 cases (3.8%). The сomplications included: in 5 (3.1%) cases, patients had pain after the procedure, and in 37 (22.7%) cases there was a hematoma. In 5 (3.1%) patients, residual tissue was found at the site of removed lesions. CONCLUSIONS: VAB is a safe alternative to exploratory surgery in patients with B3 lesions diagnosed by core biopsy.

Publisher

Baltic Medical Education Center

Subject

General Medicine

Reference12 articles.

1. Lucioni M., Rossi C., Lomoro P. et al. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? // Eur. Radiol. 2021. Vol. 31, No. 2. Р. 920–927. doi: 10.1007/s00330-020-07161-5.

2. Forester N.D., Lowes S., Mitchell E., Twiddy M. High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis // Eur. J. Surg. Oncol. 2019. Vol. 45, No. 4. Р. 519–527. doi: 10.1016/j.ejso.2018.12.008.

3. Andreu F.J., Sáez A., Sentís M. et al. Breast core biopsy reporting categories — аn internal validation in a series of 3054 consecutive lesions // Breast. 2007. Vol. 16, No. 1. Р. 94–101. doi: 10.1016/j.breast.2006.06.009.

4. Eusebi V., Feudale E., Foschini M.P. et al. Long-term follow-up of in situ carcinoma of the breast // Semin. Diagn Pathol. 1994. Vol. 11, No. 3 Р. 223–235.

5. Perry N., Broeders M., de Wolf C., Törnberg S., Holland R., von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition — summary document // Ann. Oncol. 2008. Vol. 19, No. 4. Р. 614–622. doi: 10.1093/annonc/mdm481.